JP2020516613A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516613A5 JP2020516613A5 JP2019554924A JP2019554924A JP2020516613A5 JP 2020516613 A5 JP2020516613 A5 JP 2020516613A5 JP 2019554924 A JP2019554924 A JP 2019554924A JP 2019554924 A JP2019554924 A JP 2019554924A JP 2020516613 A5 JP2020516613 A5 JP 2020516613A5
- Authority
- JP
- Japan
- Prior art keywords
- nhco
- groups
- antibody
- aspects
- nhc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023066568A JP2023100679A (ja) | 2017-04-07 | 2023-04-14 | 新規化合物及びそれらの治療上の使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1705686.2A GB201705686D0 (en) | 2017-04-07 | 2017-04-07 | Novel compounds and therapeutic uses thereof |
| GB1705686.2 | 2017-04-07 | ||
| PCT/GB2018/050928 WO2018185495A1 (en) | 2017-04-07 | 2018-04-06 | Novel compounds and therapeutic uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023066568A Division JP2023100679A (ja) | 2017-04-07 | 2023-04-14 | 新規化合物及びそれらの治療上の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516613A JP2020516613A (ja) | 2020-06-11 |
| JP2020516613A5 true JP2020516613A5 (enExample) | 2021-04-30 |
| JP7695773B2 JP7695773B2 (ja) | 2025-06-19 |
Family
ID=58744828
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019554924A Active JP7695773B2 (ja) | 2017-04-07 | 2018-04-06 | 新規化合物及びそれらの治療上の使用 |
| JP2023066568A Pending JP2023100679A (ja) | 2017-04-07 | 2023-04-14 | 新規化合物及びそれらの治療上の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023066568A Pending JP2023100679A (ja) | 2017-04-07 | 2023-04-14 | 新規化合物及びそれらの治療上の使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11766483B2 (enExample) |
| EP (1) | EP3606561B1 (enExample) |
| JP (2) | JP7695773B2 (enExample) |
| KR (1) | KR102646581B1 (enExample) |
| CN (1) | CN110753558B (enExample) |
| AU (1) | AU2018248706B2 (enExample) |
| CA (1) | CA3059018A1 (enExample) |
| ES (1) | ES2954294T3 (enExample) |
| GB (1) | GB201705686D0 (enExample) |
| IL (1) | IL270460B2 (enExample) |
| WO (1) | WO2018185495A1 (enExample) |
| ZA (1) | ZA201906580B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201816553D0 (en) | 2018-10-10 | 2018-11-28 | Centauri Therapeutics Ltd | Novel compounds and therapeutic uses thereof |
| GB202406865D0 (en) | 2024-05-15 | 2024-06-26 | Centauri Therapeutics Ltd | Novel compounds and therapeutics uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6090381A (en) | 1997-02-11 | 2000-07-18 | Immunomedics, Inc. | Stimulation of an immune response with antibodies labeled with the . .alpha-galactosyl epitope |
| FR2801305B1 (fr) | 1999-11-24 | 2002-12-06 | Galderma Res & Dev | Analogues de la vitamine d |
| US7645743B2 (en) | 1999-12-22 | 2010-01-12 | Altermune, Llc | Chemically programmable immunity |
| FI20011664L (fi) | 2001-08-17 | 2003-02-18 | Carbion Oy | Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö |
| JP2005535723A (ja) | 2002-08-20 | 2005-11-24 | バイオティ セラピィーズ コープ | 腫瘍特異的オリゴ糖エピトープおよびその用途 |
| US7585886B2 (en) * | 2005-05-19 | 2009-09-08 | Astellas Pharma Inc. | Pyrrolidine derivative or salt thereof |
| FR2886298A1 (fr) * | 2005-05-24 | 2006-12-01 | Ifremer | Anticorps ou fragment d'anticorps couple a un agent immunogene |
| CN105709237A (zh) * | 2005-12-16 | 2016-06-29 | Ibc 医药公司 | 基于免疫球蛋白的多价生物活性装配体 |
| US20100173323A1 (en) * | 2006-06-09 | 2010-07-08 | University Of Maryland, Baltimore | Glycosylation engineered antibody therapy |
| WO2009134891A2 (en) * | 2008-04-29 | 2009-11-05 | Immunexcite, Inc. | Immunomodulating compositions and methods of use thereof |
| CA2716622A1 (en) | 2008-02-26 | 2009-09-03 | The Regents Of The University Of California | Glycopeptides and methods of making and using them |
| US9079880B2 (en) * | 2010-07-07 | 2015-07-14 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
| JP6111276B2 (ja) * | 2012-03-17 | 2017-04-05 | ポリフォー・アクチェンゲゼルシャフトＰｏｌｙｐｈｏｒ Ａｇ | コンホメーション制約された全合成されたマクロ環化合物 |
| US9556167B2 (en) * | 2012-05-02 | 2017-01-31 | Yale University | TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs) |
| AU2015282627B2 (en) * | 2014-06-30 | 2020-04-02 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
| GB201517859D0 (en) * | 2015-10-08 | 2015-11-25 | Altermune Ltd | Novel compounds and therapeutic uses thereof |
| US11014966B2 (en) * | 2016-09-13 | 2021-05-25 | Centuari Therapeutics Limited | Compounds and therapeutics uses thereof |
-
2017
- 2017-04-07 GB GBGB1705686.2A patent/GB201705686D0/en not_active Ceased
-
2018
- 2018-04-06 ES ES18717680T patent/ES2954294T3/es active Active
- 2018-04-06 AU AU2018248706A patent/AU2018248706B2/en active Active
- 2018-04-06 JP JP2019554924A patent/JP7695773B2/ja active Active
- 2018-04-06 WO PCT/GB2018/050928 patent/WO2018185495A1/en not_active Ceased
- 2018-04-06 CA CA3059018A patent/CA3059018A1/en active Pending
- 2018-04-06 US US16/603,579 patent/US11766483B2/en active Active
- 2018-04-06 EP EP18717680.5A patent/EP3606561B1/en active Active
- 2018-04-06 CN CN201880037436.4A patent/CN110753558B/zh active Active
- 2018-04-06 KR KR1020197032866A patent/KR102646581B1/ko active Active
- 2018-04-08 IL IL270460A patent/IL270460B2/en unknown
-
2019
- 2019-10-07 ZA ZA2019/06580A patent/ZA201906580B/en unknown
-
2023
- 2023-04-14 JP JP2023066568A patent/JP2023100679A/ja active Pending